Petros Pharmaceuticals Pink Sheet Forward View - Simple Regression

Petros Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Petros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Petros using various technical indicators. When you analyze Petros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. Simple Regression model is a single variable regression model that attempts to put a straight line through Petros Pharmaceuticals price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Petros Pharmaceuticals Simple Regression Price Forecast For the 30th of January

Given 90 days horizon, the Simple Regression forecasted value of Petros Pharmaceuticals on the next trading day is expected to be 0.01 with a mean absolute deviation of 0, mean absolute percentage error of 0.00000357, and the sum of the absolute errors of 0.1.

Petros Pharmaceuticals Pink Sheet Forecast Pattern

Backtest Petros Pharmaceuticals

Petros Pharmaceuticals Price Prediction

Buy or Sell Advice

Petros Pharmaceuticals Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Petros Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Petros Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Petros Pharmaceuticals historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Petros Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Petros Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.01 10.40 Details

Intrinsic Valuation Low Real High 0.00 0.01 10.40 Details

Bollinger Band Projection (param) Low Middle High 0.01 0.01 0.01 Details

Petros Pharmaceuticals After-Hype Price Density Analysis

Petros Pharmaceuticals Estimiated After-Hype Price Volatility

Petros Pharmaceuticals Pink Sheet Price Outlook Analysis

Notes

Petros Pharmaceuticals Hype Timeline

Petros Pharmaceuticals is at this time traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Petros is projected to increase in value after the next headline, with the price projected to jump to 0.01 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 25.0%, whereas the daily expected return is at this time at -0.88%. The volatility of related hype on Petros Pharmaceuticals is about 86583.33%, with the expected price after the next announcement by competition of 0.02. Petros Pharmaceuticals currently holds 7.39 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Petros Pharmaceuticals has a current ratio of 3.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Petros Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Petros Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Petros Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Petros to invest in growth at high rates of return. When we think about Petros Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be within a week. Check out Historical Fundamental Analysis of Petros Pharmaceuticals to cross-verify your projections.

Petros Pharmaceuticals Related Hype Analysis

Other Forecasting Options for Petros Pharmaceuticals

For every potential investor in Petros, whether a beginner or expert, Petros Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Petros Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Petros. Basic forecasting techniques help filter out the noise by identifying Petros Pharmaceuticals' price trends.

Petros Pharmaceuticals Related Equities

Risk & Return

Correlation

Petros Pharmaceuticals Market Strength Events

Petros Pharmaceuticals Risk Indicators

Story Coverage note for Petros Pharmaceuticals

Petros Pharmaceuticals Short Properties

Other Information on Investing in Petros Pink Sheet